Policy recommendations for addressing privacy challenges associated with cell-based research and interventions

BMC Medical Ethics

Volumn 15, Issue 1, 2014, Pages

  Ogbogu, Ubaka ^a   Burningham, Sarah ^a   Ollenberger, Adam ^a   Calder, Kathryn ^b   Du, Li ^a   El Emam, Khaled ^c   Hyde Lay, Robyn ^a   Isasi, Rosario ^d   Joly, Yann ^d   Kerr, Ian ^c   Malin, Bradley ^e   McDonald, Michael ^f   Penney, Steven ^a   Piat, Gayle ^a   Roy, Denis Claude ^g   Sugarman, Jeremy ^h   Vercauteren, Suzanne ^f   Verhenneman, Griet ⁱ   West, Lori ^j   Caulfield, Timothy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF MONTREAL   (Canada)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

^j UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANONYMOUS TESTING; ARTICLE; CONFIDENTIALITY; ETHICS; FEMALE; HUMAN; INFORMED CONSENT; LEGAL ASPECT; MALE; MANAGEMENT; METHODOLOGY; ORGANIZATION; RESEARCH SUBJECT; STEM CELL RESEARCH;

ANONYMOUS TESTING; CONFIDENTIALITY; CONGRESSES AS TOPIC; FEMALE; HUMANS; INFORMED CONSENT; MALE; POLICY MAKING; RESEARCH DESIGN; RESEARCH SUBJECTS; STEM CELL RESEARCH;

EID: 84893195211     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-15-7     Document Type: Article

References (84)

1. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872
2. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920
3. Human embryonic stem cells derived by somatic cell nuclear transfer. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner-Hedges R, Ma H, Kang E, Fulati A, Lee H-S, Sritanaudomchai H, Masterson K, Larson J, Eaton D, Sadler-Fredd K, Battaglia D, Lee D, Wu D, Jensen J, Patton P, Gokhale S, Stouffer RL, Wolf D, Mitalipov S, Cell 2013 153 1228 1238
4. Human oocytes reprogram somatic cells to a pluripotent state. Noggle S, Fung HL, Gore A, Martinez H, Satriani KC, Prosser R, Oum K, Paull D, Druckenmiller S, Freeby M, Greenberg E, Zhang K, Goland R, Sauer MV, Leibel RL, Egli D, Nature 2011 478 70 75
5. Stem cells and regenerative medicine: From research to clinical applications. Chalmers DRC, Rathjen PD, Rathjen J, Nicol D, J Law Med 2013 20 831 844
6. Stem cells: will they ever be the same? Pryzkhova M, Regen Med 2013 8 97 99
7. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Abyzov A, Mariani J, Palejev D, Zhang Y, Haney MS, Tomasini L, Ferrandino AF, Rosenberg Belmaker LA, Szekely A, Wilson M, Kocabas A, Calixto NE, Grigorenko EL, Huttner A, Chawarska K, Weissman S, Urban AE, Gerstein M, Vaccarino FM, Nature 2012 492 438 442
8. iPS cells: mapping the policy issues. Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, Heine H, Isasi R, Kato K, Lovell-Badge R, McNagy K, Pei D, Rossant J, Surani A, Taylor PL, Ogbogu U, Caulfield T, Cell 2009 139 1032 1037
9. From genetic privacy to open consent. Lunshof JE, Chadwick R, Vorhaus DB, Church GM, Nat Rev Genet 2008 9 406 411
10. Assessing and managing risk when sharing aggregate genetic variant data. Craig DW, Goor RM, Wang Z, Paschall J, Ostell J, Feolo M, Sherry ST, Manolio TA, Nat Rev Genet 2011 12 730 736
11. Disclosure and management of research findings in stem cell research and banking: policy statement. Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F, Regen Med 2012 7 439 448
12. The stem cell research environment: a patchwork of patchworks. Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Premji S, von Tigerstrom B, Winickoff DE, Stem Cell Rev Rep 2009 5 82 88
13. International stem cell environments: a world of difference. Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Premji S, von Tigerstrom B, Winickoff DE, Nature Reports Stem Cells 2009 doi:10.1038/stemcells.2009.61
14. Policy interoperability in stem cell research: demystifying harmonization. Isasi RM, Stem Cell Rev Rep 2009 5 108 115
15. From banking to international governance: fostering innovation in stem cell research. Isasi R, Knoppers BM, Stem Cells Intl 2011 doi:10.4061/2011/ 498132
16. Harmonisation and standardisation in ethics and governance: conceptual and practical challenges. Chadwick R, Strange H, The Governance of Genetic Information: Who Decides? Volume 9 Cambridge: Cambridge University Press, Widdows H, Mullen C, 2009 201 213
17. Genomic research and human subject privacy. Lin Z, Owen AB, Altman RB, Science 2004 305 183
18. Identifying personal genomes by surname inference. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y, Science 2013 339 321 324
19. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW, PLoS Genet 2008 4 1000167
20. Caught you: threats to confidentiality due to the public release of large-scale genetic data sets. Wjst M, BMC Med Ethics 2010 11 21
21. Identifiability in biobanks: models, measures, and mitigation strategies. Malin B, Loukides G, Benitez K, Clayton EW, Hum Genet 2011 130 383 392
22. Re-identification of familial database records. Malin B, AMIA Annu Symp Proc 2006 2006 524 528
23. A systematic review of re-identification attacks on health data. El Emam K, Jonker E, Arbuckle L, Malin B, PLoS One 2011 6 28071
24. How anonymous is 'anonymous'? Some suggestions towards a coherent universal coding system for genetic samples. Schmidt H, Callier S, J Med Ethics 2012 38 304 309
25. Genomic data disclosure: time to reassess the realities. Greenbaum D, Am J Bioeth 2013 13 5 47 50
26. Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). Joly Y, Dove ES, Knoppers BM, Bobrow M, Chalmers D, PLoS Comput Biol 2012 8 1002549
27. Kolata G, Web Hunt for DNA Sequences Leaves Privacy Compromised New York Times
28. Ferguson W, A Hacked Database Prompts Debate about Genetic Privacy Scientific American 2013 http://www.scientificamerican.com/article.cfm?id=a- hacked-database-prompts
29. BBC News, Donated Genetic Data 'Privacy Risk 2013 http://www.bbc.co.uk/ news/health-21056647
30. Tanner A, Harvard Professor re-identifies Anonymous Volunteers in DNA Study Forbes 2013 http://www.forbes.com/sites/adamtanner/2013/04/25/harvard- professor-re-identifies-anonymous-volunteers-in-dna-study/
31. Skloot R, The Immortal Life of Henrietta Lacks, The Sequel New York Times 2013 http://www.nytimes.com/2013/03/24/opinion/sunday/the-immortal-life-of- henrietta-lacks-the-sequel.html?pagewanted=all
32. Coghlan A, Storm Erupts Over Publishing of HeLa Genome New Scientist http://www.newscientist.com/article/dn23330-storm-erupts-over-publishing-of- hela-genome.html
33. Kroll D, The Henrietta Lacks Genome: Consent, Trust, and Common Decency Forbes http://www.forbes.com/sites/davidkroll/2013/03/24/the-henrietta-lacks- genome-consent-trust-and-common-decency/
34. Presidential Commission for the Study of Bioethical Issues, Privacy and Progress in Whole Genome Sequencing Washington, DC 2012 http://bioethics.gov/ node/764
35. Identifiability in genomic research. Lowrance WW, Collins FS, Science 2007 317 600 602
36. Genetic discrimination in private insurance: global perspectives. Joly Y, Braker M, Le Huynh M, New Genet Soc 2010 29 351 368
37. Tissue donation to biobanks: a review of sociological studies. Lipworth W, Forsyth R, Kerridge I, Sociol Health Illn 2011 33 792 811
38. Data re-identification: societal safeguards. Altman RB, Clayton EW, Kohane IS, Malin BA, Roden DM, Science 2013 339 1032 1033
39. No longer de-identified. McGuire AL, Gibbs RA, Science 2006 312 370 371
40. The complexities of genomic identifiability. Rodriguez LL, Brooks LD, Greenberg JH, Green ED, Science 2013 339 275 276
41. NCI think tank concerning the identifiability of biospecimens and omic data. Weil CJ, Mechanic LE, Green T, Kinsinger C, Lockhart NC, Nelson SA, Rodriguez LL, Buccini LD, Genet Med 2013 doi:10.1038/gim.2013.40
42. Genetic discrimination and life insurance: a systematic review of the evidence. Joly Y, Ngueng Feze I, Simard J, BMC Med 2013 11 25
43. Genetic information and life insurance: a 'real' risk? Joly Y, Knoppers BM, Godard B, Eur J Hum Genet 2003 11 561 564
44. Genetics and insurance in the United Kingdom 1995-2010: the rise and fall of 'scientific' discrimination. Thomas RG, New Genet Soc 2012 31 203 222
45. The biobanking quandary: getting and withdrawing consent. Caulfield T, Harvard Health Policy Rev 2011 12 21 24
46. Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. Aalto-Setälä K, Conklin BR, Lo B, PLoS Biol 2009 7 1000042
47. Biobanking human biological materials: issues surrounding the collection of samples for use in future research. Kapp M, Pharmaceut Med 2008 22 75 84
48. Canadian Institutes of Health Research, Updated Guidelines for Human Pluripotent Stem Cell Research 2010 http://www.cihr-irsc.gc.ca/e/42071.html
49. Academies N, Guidelines for Human Embryonic Stem Cell Research Washington, DC: National Academies Press 2005
50. Stem Cell Network, Use of Human Embryos for Stem Cell Research http://www.stemcellnetwork.ca/uploads/document-library/policy-papers/ policy-humanembryo.pdf
51. International Society for Stem Cell Research, Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006) http://www.isscr.org/home/ publications/guide-clintrans
52. Broadening consent-and diluting ethics? Hoffman B, J Med Ethics 2009 35 125 129
53. Informed consent in embryonic stem cell research: are we following basic principles? Caulfield T, Ogbogu U, Isasi RM, CMAJ 2007 176 1722 1725
54. Biobanks, consent and claims of consensus. Master Z, Nelson E, Murdoch B, Caulfield T, Nat Methods 2012 9 885 888
55. Potential harms, anonymization, and the right to withdraw consent to biobank research. Eriksson S, Helgesson G, Eur J Hum Genet 2005 13 1071 1076
56. Withdrawal from biobank research: considerations and the way forward. Hug K, Hermerén G, Johansson M, Stem Cell Rev 2012 8 1056 1065
57. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans http://www.ethics.gc.ca/pdf/eng/tcps2/TCPS-2-FINAL-Web.pdf
58. Protection of Human Subjects (Common Rule), 45 CFR §46.116 http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.116
59. National Health and Medical Research Council, Australian Research Council, Australian Vice-Chancellors' Committee, National Statement on Ethical Conduct in Human Research http://www.nhmrc.gov.au/guidelines/publications/e72
60. Directives EC, Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the Approximation of the Laws, Regulations and Administrative Provisions of the Member States Relating to the Implementation of Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use, [2001] OJ L 121/34 http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2001:121:0034:0044:en:PDF
61. European Commission-CORDIS-Seventh Framework Programme (FP7), Guidance for Applicants: Informed Consent http://ec.europa.eu/research/participants/data/ ref/fp7/89807/informed-consent-en.pdf
62. UK Department of Health, Reference Guide to Consent for Examination or Treatment (2nd ed) https://www.gov.uk/government/publications/reference-guide- to-consent-for-examination-or-treatment-second-edition
63. Research ethics recommendations for whole-genome research: consensus statement. Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, Meslin EM, Murphy J, Nussbaum RL, Otlowski M, Pullman D, Ray PN, Sugarman J, Timmons M, PLoS Biol 2008 6 73
64. Stem cell research ethics: consensus statement on emerging issues. Caulfield T, Ogbogu U, Nelson E, Einsiedel E, Knoppers B, McDonald M, Brunger F, Downey R, Fernando K, Galipeau J, Geransar R, Griener G, Hyun I, Isasi R, Kardel M, Knowles L, Kucic T, Lotjonen S, Lyall D, Magnus D, Mathews DJ, Nisbet M, Nisker J, Pare G, Pattinson S, Pullman D, Rudnicki M, Williams-Jones B, Zimmerman S, J Obstet Gynaecol Can 2007 29 843 848
65. Privacy protection and genetic research: where does the public interest lie? Ogbogu U, Burningham S, Alberta Law Review 2014 51 3 in press
66. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Gollust SE, Gordon ES, Zayac C, Griffin G, Christman MF, Pyeritz RE, Wawak L, Bernhardt BA, Public Health Genomics 2012 15 22 30
67. Public opinion and trust in scientists: the role of the research context, and the perceived motivation of stem cell researchers. Critchley CR, Public Underst Sci 2008 17 309 327
68. Cancer patient perceptions on the ethical and legal issues related to biobanking. Master Z, Claudio JO, Rachul C, Wang JC, Minden MD, Caulfield T, BMC Med Genomics 2013 6 8
69. The right to control and access genetic research information: does McInerney offer a way out of the consent/withdrawal conundrum? Ogbogu U, Burningham S, Caulfield T, UBC Law Review 2014 47 1 in press
70. National Academy of Sciences, Board on Biology, and National Research Council: Privacy Issues in Biomedical and Clinical Research Washington, DC: National Academies Press 2008
71. National Cancer Institute (Ed), NCI Best Practices for Biospecimen Resources http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices. pdf.
72. International Cancer Genome Consortium, Policy on Informed Consent, Access and Ethical Oversight http://icgc.org/icgc/goals-structure-policies- guidelines/e1-informed-consent-access-and-ethical-oversight
73. Australian Medical Association, Position Statement on Genetic Testing 2012 https://ama.com.au/position-statement/genetic-testing-2012
74. Council for International Organizations of Medical Sciences, International Ethical Guidelines for Biomedical Research Involving Human Subjects http://www.cioms.ch/publications/layout-guide2002.pdf
75. Organization for Economic Cooperation and Development, OECD Guidelines on Human Biobanks and Genetic Research Databases http://www.oecd.org/science/ biotechnologypolicies/44054609.pdf
76. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction: Guideline for Obtaining Informed Consent for the Procurement and Use of Human Tissues, Cells and Fluids in Research http://www.who.int/reproductivehealth/topics/ethics/human-tissue-use. pdf
77. Council of Europe, Committee of Ministers, Recommendation Rec(2006)4 of the Committee of Ministers to member states on research on biological materials of human origin https://wcd.coe.int/ViewDoc.jsp?id=977859
78. Toward a National Framework for the Secondary Use of Health Data: An American Medical Informatics Association White Paper. Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, Detmer DE, J Am Med Inform Assoc 2007 14 1 9
79. Trustworthy reuse of health data: A transnational perspective. Geissbuhler A, Safran C, Buchan I, Bellazzi R, Labkoff S, Eilenberg K, Leese A, Richardson C, Mantas J, Murray P, De Moor G, Int J Med Inform 2012 82 1 9
80. Towards a data sharing Code of Conduct for international genomic research. Knoppers BM, Harris JR, Tassé AM, Budin-Ljøsne I, Kaye J, Deschênes M, Zawati MH, Genome Med 2011 3 46
81. The governance of research involving human participants in Canada. Hirtle M, Health Law J 2003 11 137 152
82. Canadian governance of health research involving human subjects: is anybody minding the store? McDonald M, Health Law J 2001 9 1 21
83. Kerr I, The Devil is in the Defaults Ottawa Citizen 2010 http://www2.canada.com/ottawacitizen/story.html?id=f3fc40da-dee3-4a1d-bf05- d35301352010
84. Genomic databases access agreements: legal validity and possible sanctions. Joly Y, Zeps N, Knoppers BM, Hum Genet 2011 130 441 449